Hima Anbunathan1, Ruth Verstraten1,2, Arun D Singh3, J William Harbour4, Anne M Bowcock5,2,6. 1. National Heart and Lung Institute, Imperial College, London, United Kingdom. 2. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. 3. Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio. 4. Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida. 5. National Heart and Lung Institute, Imperial College, London, United Kingdom. anne.bowcock@mssm.edu. 6. Departments of Dermatology and Genetics & Genome Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Authors: H M Hurks; M M Valter; L Wilson; I Hilgert; P J van den Elsen; M J Jager Journal: Invest Ophthalmol Vis Sci Date: 2001-12 Impact factor: 4.799
Authors: N V Soshnikova; E V Tatarskiy; V V Tatarskiy; N S Klimenko; A A Shtil; M A Nikiforov; S G Georgieva Journal: Oncogene Date: 2021-08-31 Impact factor: 9.867
Authors: Yasemin C Cole; Yu-Zhi Zhang; Beatrice Gallo; Adam P Januszewski; Anca Nastase; David J Essex; Caroline M H Thaung; Victoria M L Cohen; Mandeep S Sagoo; Anne M Bowcock Journal: Cancers (Basel) Date: 2022-08-25 Impact factor: 6.575